{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:08:23Z","timestamp":1707523703832},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,24]]},"DOI":"10.7759\/cureus.35407","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T14:26:51Z","timestamp":1677248811000},"source":"Crossref","is-referenced-by-count":0,"title":["Bisphosphonates Prescription for Patients With Hip Fractures Based on Evaluation by a Dentist"],"prefix":"10.7759","author":[{"given":"Hayato","family":"Inoue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryunosuke","family":"Oyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimitaka","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Inokuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teiyu","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuta","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Ebihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Arizono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"International Osteoporosis Foundation. Asian Audit. (2009). https:\/\/www.osteoporosis.foundation\/educational-hub\/files\/asian-audit-2009."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001155.pub2","article-title":"Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women","volume":"23","author":"Wells GA","year":"2008","unstructured":"Wells GA, Cranney A, Peterson J, et al.. Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev. 2008, 23:CD001155. 10.1002\/14651858.CD001155.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2018.03.018","article-title":"Fracture liaison services improve outcomes of patients with osteoporosis-related fractures: a systematic literature review and meta-analysis","volume":"111","author":"Wu CH","year":"2018","unstructured":"Wu CH, Tu ST, Chang YF, et al.. Fracture liaison services improve outcomes of patients with osteoporosis-related fractures: a systematic literature review and meta-analysis. Bone. 2018, 111:92-100. 10.1016\/j.bone.2018.03.018","journal-title":"Bone"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S85551","article-title":"Fracture liaison services: improving outcomes for patients with osteoporosis","volume":"12","author":"Walters S","year":"2017","unstructured":"Walters S, Khan T, Ong T, Sahota O. Fracture liaison services: improving outcomes for patients with osteoporosis. Clin Interv Aging. 2017, 12:117-27. 10.2147\/CIA.S85551","journal-title":"Clin Interv Aging"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-019-01047-3","article-title":"Ten years change in post-fracture care for hip fracture patients","volume":"38","author":"Shimodan S","year":"2020","unstructured":"Shimodan S, Sato D, Takahashi K, et al.. Ten years change in post-fracture care for hip fracture patients. J Bone Miner Metab. 2020, 38:222-9. 10.1007\/s00774-019-01047-3","journal-title":"J Bone Miner Metab"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-014-2827-x","article-title":"Post-fracture pharmacotherapy for women with osteoporotic fracture: analysis of a managed care population in the USA","volume":"25","author":"Wilk A","year":"2014","unstructured":"Wilk A, Sajjan S, Modi A, Fan CP, Mavros P. Post-fracture pharmacotherapy for women with osteoporotic fracture: analysis of a managed care population in the USA. Osteoporos Int. 2014, 25:2777-86. 10.1007\/s00198-014-2827-x","journal-title":"Osteoporos Int"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2015.01.014","article-title":"Use of osteoporosis medications after hospitalization for hip fracture: a cross-national study","volume":"128","author":"Kim SC","year":"2015","unstructured":"Kim SC, Kim MS, Sanf\u00e9lix-Gimeno G, et al.. Use of osteoporosis medications after hospitalization for hip fracture: a cross-national study. Am J Med. 2015, 128:519-26.e1. 10.1016\/j.amjmed.2015.01.014","journal-title":"Am J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jos.2018.12.029","article-title":"Clinical characteristics of osteoporotic second hip fracture: from the data of Clinical Pathway with Regional Alliance in rural region in Japan","volume":"24","author":"Yoshii I","year":"2019","unstructured":"Yoshii I, Kitaoka K, Hashimoto K. Clinical characteristics of osteoporotic second hip fracture: from the data of Clinical Pathway with Regional Alliance in rural region in Japan. J Orthop Sci. 2019, 24:836-41. 10.1016\/j.jos.2018.12.029","journal-title":"J Orthop Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00590-019-02412-8","article-title":"Short-term risk factors for a second hip fracture in a UK population","volume":"29","author":"Sheikh HQ","year":"2019","unstructured":"Sheikh HQ, Hossain FS, Khan S, Usman M, Kapoor H, Aqil A. Short-term risk factors for a second hip fracture in a UK population. Eur J Orthop Surg Traumatol. 2019, 29:1055-60. 10.1007\/s00590-019-02412-8","journal-title":"Eur J Orthop Surg Traumatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-017-0364-2","article-title":"Second hip fracture: incidence, trends, and predictors","volume":"102","author":"Mazzucchelli R","year":"2018","unstructured":"Mazzucchelli R, P\u00e9rez-Fern\u00e1ndez E, Cresp\u00ed N, Garc\u00eda-Vadillo A, Rodriguez Caravaca G, Gil de Miguel A, Carmona L. Second hip fracture: incidence, trends, and predictors. Calcif Tissue Int. 2018, 102:619-26. 10.1007\/s00223-017-0364-2","journal-title":"Calcif Tissue Int"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-015-3104-3","article-title":"Excess mortality associated with second hip fracture","volume":"26","author":"Sobolev B","year":"2015","unstructured":"Sobolev B, Sheehan KJ, Kuramoto L, Guy P. Excess mortality associated with second hip fracture. Osteoporos Int. 2015, 26:1903-10. 10.1007\/s00198-015-3104-3","journal-title":"Osteoporos Int"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-018-4502-0","article-title":"Characteristics of recurrent fractures","volume":"29","author":"Kanis JA","year":"2018","unstructured":"Kanis JA, Johansson H, Od\u00e9n A, et al.. Characteristics of recurrent fractures. Osteoporos Int. 2018, 29:1747-57. 10.1007\/s00198-018-4502-0","journal-title":"Osteoporos Int"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-016-0810-7","article-title":"Antiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw","volume":"35","author":"Yoneda T","year":"2017","unstructured":"Yoneda T, Hagino H, Sugimoto T, et al.. Antiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw. J Bone Miner Metab. 2017, 35:6-19. 10.1007\/s00774-016-0810-7","journal-title":"J Bone Miner Metab"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/s0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx RE","year":"2003","unstructured":"Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg. 2003, 61:1115-7. 10.1016\/s0278-2391(03)00720-1","journal-title":"J Oral Maxillofac Surg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus","volume":"30","author":"Khan AA","year":"2015","unstructured":"Khan AA, Morrison A, Hanley DA, et al.. Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res. 2015, 30:3-23. 10.1002\/jbmr.2405","journal-title":"J Bone Miner Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-011-1534-0","article-title":"Fracture liaison services for the evaluation and management of patients with osteoporotic fracture: a cost-effectiveness evaluation based on data collected over 8\u00a0years of service provision","volume":"22","author":"McLellan AR","year":"2011","unstructured":"McLellan AR, Wolowacz SE, Zimovetz EA, et al.. Fracture liaison services for the evaluation and management of patients with osteoporotic fracture: a cost-effectiveness evaluation based on data collected over 8\u00a0years of service provision. Osteoporos Int. 2011, 22:2083-98. 10.1007\/s00198-011-1534-0","journal-title":"Osteoporos Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-012-2090-y","article-title":"Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta-analysis","volume":"24","author":"Ganda K","year":"2013","unstructured":"Ganda K, Puech M, Chen JS, et al.. Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta-analysis. Osteoporos Int. 2013, 24:393-406. 10.1007\/s00198-012-2090-y","journal-title":"Osteoporos Int"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/95804-bisphosphonates-prescription-for-patients-with-hip-fractures-based-on-evaluation-by-a-dentist","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:51:17Z","timestamp":1707508277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/95804-bisphosphonates-prescription-for-patients-with-hip-fractures-based-on-evaluation-by-a-dentist"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,24]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.35407","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,24]]}}}